Looking Beyond CNS, SK Biopharm Begins First US Oncology Trial

Aims To Double Business This Year

 
• By Jung Won Shin
  
Jeong Woo Cho, CEO Of SK Biopharmaceuticals
M&A Also On The Table To Accelerate Product Launches • Source: SK Biopharmaceuticals Co. Ltd.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from South Korea

More from Focus On Asia